Is Our Newborn Screening Working Well? A Literature Review of Quality Requirements for Newborn Blood Spot Screening (NBS) Infrastructure and Procedures

被引:10
|
作者
Odenwald, Birgit [1 ]
Brockow, Inken [1 ]
Hanauer, Marianne [1 ]
Lueders, Anja [1 ]
Nennstiel, Uta [1 ]
机构
[1] Bavarian Hlth & Food Safety Author, State Inst Hlth, Newborn Screening Ctr, D-85764 Oberschleissheim, Germany
关键词
newborn screening; neonatal screening; dried blood spots; screening programme; evaluation; process quality; quality management; TERM-FOLLOW-UP; PUBLIC-HEALTH; CYSTIC-FIBROSIS; PAIN-MANAGEMENT; PARENTS; CONSENT; COMMUNICATION; PROFESSIONALS; EDUCATION; DISEASE;
D O I
10.3390/ijns9030035
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Newborn screening using dried blood spots (NBS) is widely acknowledged as a highly successful procedure in secondary prevention. For a number of congenital disorders, severe disability or death are impressively prevented by early detection and early treatment through NBS. However, as with any other screening, NBS can also cause harm, and the principle that "the overall benefits of screening should outweigh the harms" must be considered when introducing and implementing NBS programmes. This publication compiles the results of a systematic literature research on requirements for NBS infrastructure and procedures which was conducted as part of a research project on the quality and shortcomings of the NBS pathway in Germany. The compilation contains the requirements and recommendations for realising the principle of "maximise benefits and minimise harms" in relevant NBS pathway components such as parental education and information, coverage, timeliness, laboratory quality assurance, follow-up of abnormal results, confirmatory diagnostics, documentation, and evaluation. The results reflect the complexity of NBS infrastructure, and thus, they illustrate the importance of considering and implementing NBS as a well-coordinated public health programme with continuous quality management. Special attention should be paid to the perspectives of parents and families. Some NBS issues can substantially benefit from digital instruments or international cooperation. The literature review presented here has contributed to a concept of proposals for the advancement of NBS in Germany, and despite different settings, it may as well be of interest for other countries to achieve the best possible course and outcome of NBS for each child.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Newborn blood spot screening (NBS) in Germany. Status quo and presentation of a concept for further development
    Nennstiel, Uta
    Odenwald, Birgit
    Throner, Veronika
    Blankenstein, Oliver
    Vieth, Andreas
    Ratzel, Rudolf
    Coenen, Michaela
    Brockow, Inken
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2023, 66 (11) : 1195 - 1204
  • [2] Screening for disease in the newborn: the evidence base for blood-spot screening
    Wilcken, Bridget
    PATHOLOGY, 2012, 44 (02) : 73 - 79
  • [3] The evolution of blood-spot newborn screening
    Bhattacharya, Kaustuv
    Wotton, Tiffany
    Wiley, Veronica
    TRANSLATIONAL PEDIATRICS, 2014, 3 (02): : 63 - 70
  • [4] Economic impact of screening for X-linked Adrenoleukodystrophy within a newborn blood spot screening programme
    Bessey, Alice
    Chilcott, James B.
    Leaviss, Joanna
    Sutton, Anthea
    ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
  • [5] Informed Choice for Newborn Blood Spot Screening in the United Kingdom: A Survey of Parental Perceptions
    Nicholls, Stuart G.
    Southern, Kevin W.
    PEDIATRICS, 2012, 130 (06) : E1527 - E1533
  • [6] A computer vision approach to the assessment of dried blood spot size and quality in newborn screening
    Flynn, Nick
    Moat, Stuart J.
    Hogg, Sarah L.
    CLINICA CHIMICA ACTA, 2023, 547
  • [7] Newborn blood spot screening in four countries: Stakeholder involvement
    Potter, Beth K.
    Avard, Denise
    Wilson, Brenda J.
    JOURNAL OF PUBLIC HEALTH POLICY, 2008, 29 (01) : 121 - 142
  • [8] Newborn Blood Spot Screening in Four Countries: Stakeholder Involvement
    Beth K Potter
    Denise Avard
    Brenda J Wilson
    Journal of Public Health Policy, 2008, 29 : 121 - 142
  • [9] Economic impact of screening for X-linked Adrenoleukodystrophy within a newborn blood spot screening programme
    Alice Bessey
    James B Chilcott
    Joanna Leaviss
    Anthea Sutton
    Orphanet Journal of Rare Diseases, 13
  • [10] Newborn blood spot screening for cystic fibrosis with a four-step screening strategy in the Netherlands
    Dankert-Roelse, Jeannette E.
    Bouva, Marelle J.
    Jakobs, Bernadette S.
    Janssens, Hettie M.
    de Winter-de Groot, Karin M.
    Schonbeck, Yvonne
    Gille, Johan J. P.
    Gulmans, Vincent A. M.
    Verschoof-Puite, Rendelien K.
    Schielen, Peter C. J. I.
    Verkerk, Paul H.
    JOURNAL OF CYSTIC FIBROSIS, 2019, 18 (01) : 54 - 63